Prevalence and Clinical Impact of Donor-Specific Alloantibody Among Intestinal Transplant Recipients

Abstract

The presence of DSA is associated with inferior graft outcomes among intestinal transplant recipients. An enhanced understanding of the mechanisms by which DSA causes allograft injury, and effective strategies targeting humoral immune reactivity are needed to improve long-term intestinal graft outcomes.